EQS Newsfeed

Corpare News, Press, Analysis

Made with ❤ von BGFL
#BGFLapp * beta

EQS News is by far the most important platform for official company news. Boersengefluester.de combines the latest ad-hoc announcements or other company news from our database, meaningful share charts and other useful links from the BGFL data pool, thus creating added value for investors who prefer to obtain timely and meaningful information from the original source. Tip: You are also welcome to use our newsfeed focussing on the latest analyst research to round things off.

08.12.2025 02:53PM

Termination of Maximilian Foerst’s Executive Board mandate as of 31 December 2025 and interim assumption of the CEO role by Andreas Pecher as of 1 January 2026

Termination of Maximilian Foerst’s Executive Board mandate as of 31 December 2025 and interim assumption of the CEO role by Andreas Pecher as of 1 January 2026 – interim assumption of the Chairmanship of the Supervisory Board by Peter Kameritsch   Jena, 8 December 2025 The Supervisory Board of Carl Zeiss Meditec AG (ISIN: DE0005313704)  [ … ]
08.12.2025 07:00AM

Evotec closes sale of Just – Evotec Biologics’ Toulouse site to Sandoz

All closing requirements satisfied following announcement of a non-binding term-sheet agreement in July and signing of contract in November Agreement includes approximately US$ 350 m in cash for Just – Evotec Biologics manufacturing site in Toulouse and upfront technology license fees to Evotec’s continuous manufacturing platform In additio [ … ]
05.12.2025 04:10PM

Reorganization of the Eckert & Ziegler Executive Board

Berlin, 5 December 2025. The Supervisory Board of Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) has decided to reduce the size of the Executive Board from three to two members as of 1 January 2026. The contract of Frank Yeager, member of the Executive Board and responsible for the Isotope Products segment, will end as planned on 31 December 2 [ … ]
04.12.2025 08:30AM

Evotec-partner Bayer starts Phase 2 study for treatment of patients with Alport syndrome

  Phase 2 clinical trial initiated to evaluate SEMA3A mAb as potential treatment for Alport syndrome Milestone payment to Evotec expected upon first dosing of first study participant in early 2026   Hamburg, Germany, 04 December 2025: Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 56 [ … ]
03.12.2025 09:00AM

Eckert & Ziegler and SK Biopharmaceuticals Sign Actinium-225 Supply Agreement

Berlin, Germany & Seoul, South Korea, 3 December 2025 – Eckert & Ziegler (ISIN DE0005659700, TecDAX) has signed a supply agreement with SK Biopharmaceuticals, a biotech company specializing in research, development, and commercialization of treatments of central nervous system (CNS) disorder, active in the field of radiopharma and based in  [ … ]

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
If desired, the news can be limited to certain indices (DAX, MDAX, etc.) or market segments (Prime Standard, General Standard, Scale, etc.).
Dataselect Tool Family
          EQS Newsfeed          
          Qualitätsjournalismus · Made in Germany © 2025          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2025 by Gereon Kruse #BGFL